ArticleOncotarget2017

Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis.

Severine Mollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.